NUTX Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
Nutex Health Inc. (NUTX) is not a strong buy at the moment for a beginner, long-term investor. While the company has shown significant revenue growth, its declining net income and EPS, coupled with bearish technical indicators, suggest caution. Additionally, no strong trading signals or significant positive catalysts are present to justify immediate action.
The MACD is positive and expanding, indicating some bullish momentum, but the RSI is neutral, and the moving averages are bearish (SMA_200 > SMA_20 > SMA_5). The stock is trading near its resistance level (R1: 115.874), which could limit upward movement in the short term.
The company has demonstrated strong revenue growth in 2025/Q3, with a YoY increase of 239.87%. Additionally, the upcoming earnings report and conference call on March 6, 2026, could provide further insights into the company's performance and future outlook.
Net income and EPS have significantly declined YoY (-730.78% and -551.16%, respectively), raising concerns about profitability. The press release highlights potential risks and uncertainties, which may weigh on investor sentiment. Bearish moving averages also indicate a downward trend.
In 2025/Q3, revenue increased significantly to $267.8M (up 239.87% YoY), but net income dropped to $55.4M (-730.78% YoY), and EPS fell to 7.76 (-551.16% YoY). Gross margin improved to 57.83 (up 107.87% YoY), showing operational efficiency despite profitability challenges.
No data available for analyst ratings or price target changes.
